Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of capecitabine in patients undergoing peri-operative chemotherapy and total gastrectomy for gastric adenocarcinoma
2009-009908-39Phase 4Terminated
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- Jun 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of capecitabine in gastric adenocarcinoma, sponsored by Cambridge University Hospitals NHS Foundation Trust. Primary endpoints: Capecitabine pharmacokinetic parameters post-gastrectomy, Comparison of pre- vs post-gastrectomy capecitabine pharmacokinetics and 1 more. Started Jun 2009; status: terminated.
02
Drugs
capecitabine
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on 2009-009908-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-009908-39.